Latest News about CNTA
Recent news which mentions CNTA
AeroVironment Posts Downbeat Results, Joins Box, CrowdStrike And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 05, 2025
From Benzinga
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 24, 2025
From Benzinga
Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session
November 25, 2024
From Benzinga
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
November 21, 2024
From Benzinga
Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers
September 10, 2024
From Benzinga
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
September 10, 2024
From Benzinga
Tickers
CNTA
From InvestorPlace
Tickers
CNTA
From InvestorPlace
Tickers
CNTA
From InvestorPlace
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
From InvestorPlace
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 09, 2024
From Benzinga
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday
February 09, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 27, 2023
From Benzinga
IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday
October 26, 2023
From Benzinga
From Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday
November 22, 2022
From Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
From Benzinga
FDA Grants Orphan Drug Status To Centessa's Hemophilia B Candidate
September 14, 2022
Tickers
CNTA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
August 12, 2022
From Benzinga
Goldman Sachs Maintains Neutral Rating for Centessa Pharmaceuticals: Here's What You Need To Know
August 11, 2022
Tickers
CNTA
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.